Taken together these results shed light on P4HA1 function in PDAC stroma as a molecular player of stroma deposition in pancreatic cancer development upon metabolic syndrome, ultimately suggesting hydroxyproline levels as potential PDAC biomarkers. Here, P4HA1 is linked to metabolic syndrome.